These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6431061)

  • 1. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
    Mock BH; Wellman HN
    J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultratag RBC kit for combined cardiac first-pass and multigated acquisition studies.
    Stallings LE; Cheng KT; Spicer KM; Wiegner R; Humphries JK
    J Nucl Med Technol; 1997 Mar; 25(1):44-8. PubMed ID: 9239603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
    Kelbaek H
    J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro RBC labeling with the UltraTag RBC kit versus in vivo labeling.
    Patrick ST; Glowniak JV; Turner FE; Robbins MS; Wolfangel RG
    J Nucl Med; 1991 Feb; 32(2):242-4. PubMed ID: 1992026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the UltraTag RBC kit.
    Spicer JA; Hladik WB; Mulberry WE
    J Nucl Med Technol; 1999 Jun; 27(2):132-5. PubMed ID: 10353111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc] pertechnetate.
    Hamilton RG; Alderson PO
    J Nucl Med; 1977 Oct; 18(10):1010-3. PubMed ID: 903468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
    Patel MC; Parab PB; Samuel AM; Ganatra RD
    J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine.
    Ahlgren S; Andersson K; Tolmachev V
    Nucl Med Biol; 2010 Jul; 37(5):539-46. PubMed ID: 20610158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
    Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
    J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
    Zimmer AM; Pavel DG; Karesh SM
    Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m-labeled red blood cells for the measurement of red cell mass in newborn infants: concise communication.
    Linderkamp O; Betke K; Fendel H; Klemm J; Lorenzen K; Riegel KP
    J Nucl Med; 1980 Jul; 21(7):637-40. PubMed ID: 7391836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of labeling procedures and in vivo stability of 99mTc-red blood cells.
    Ryo UY; Mohammadzadeh AA; Siddiqui A; Colombetti LG; Pinsky SM
    J Nucl Med; 1976 Feb; 17(02):133-6. PubMed ID: 1245875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.
    Callahan RJ; Froelich JW; McKusick KA; Leppo J; Strauss HW
    J Nucl Med; 1982 Apr; 23(4):315-8. PubMed ID: 6279801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution of Tc-99m(Sn)pyridoxylideneisoleucine: effects of storage and labeling conditions. Concise communication.
    Kato M
    J Nucl Med; 1979 Nov; 20(11):1189-93. PubMed ID: 536780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.